LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 48

Search options

  1. Article ; Online: Familial non-medullary thyroid carcinoma: clinico-pathological features, current knowledge and novelty regarding genetic risk factors.

    Cirello, Valentina

    Minerva endocrinology

    2020  Volume 46, Issue 1, Page(s) 5–20

    Abstract: Familial non-medullary thyroid cancer (FNMTC) constitutes 3-9% of all thyroid cancers and occurs in two or more first-degree relatives in the absence of predisposing environmental factors. Out of all FNMTC cases, only 5% are represented by syndromic ... ...

    Abstract Familial non-medullary thyroid cancer (FNMTC) constitutes 3-9% of all thyroid cancers and occurs in two or more first-degree relatives in the absence of predisposing environmental factors. Out of all FNMTC cases, only 5% are represented by syndromic forms (Gardner's Syndrome, familial adenomatous polyposis, Cowden's Syndrome, Carney complex 1, Werner's Syndrome and DICER1 syndrome), in which thyroid cancer occurs as a minor component and the genetic alterations are well-known. The non-syndromic forms represent the majority of all FNMTCs (95%), and the thyroid cancer is the predominant feature. Several low penetration susceptibility risk loci or genes (i.e. TTF1, FOXE1, SRGAP1, SRRM2, HABP2, MAP2K5, and DUOX2), here fully reviewed, have been proposed in recent years with a possible causative role, though the results are still not conclusive or reliable. FNMTC is indistinguishable from sporadic non-medullary thyroid cancer (sNMTC), which means that FNMTC cannot be diagnosed until at least one of the patient's first-degree relatives is affected by tumor. Some studies reported that the non-syndromic FNMTC is more aggressive than the sNMTC, being characterized by a younger age of onset and a higher rate of multifocal and bilateral tumors, extrathyroidal extension, lymph node metastasis, and recurrence. On the contrary, other studies did not find clinical differences between non-syndromic FNMTCs and sporadic cases. Here, I reported an extensive review on genetic and clinico-pathological features of the FNMTC, with particular attention on novel genetic risk factors for non-syndromic forms.
    MeSH term(s) Humans ; Neoplasm Recurrence, Local ; Risk Factors ; Thyroid Cancer, Papillary/genetics ; Thyroid Neoplasms/genetics
    Language English
    Publishing date 2020-10-12
    Publishing country Italy
    Document type Journal Article ; Review
    ZDB-ID 3062786-2
    ISSN 2724-6116
    ISSN (online) 2724-6116
    DOI 10.23736/S2724-6507.20.03338-6
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Poorly differentiated thyroid carcinoma: molecular, clinico-pathological hallmarks and therapeutic perspectives.

    Cirello, Valentina / Gambale, Carla / Nikitski, Alyaksandr V / Masaki, Chie / Roque, João / Colombo, Carla

    Panminerva medica

    2024  

    Abstract: Poorly differentiated thyroid carcinoma (PDTC) is a rare and extremely aggressive tumor, accounting for about 2-15% of all thyroid cancer. PDTC has a distinct biological behavior compared to well-differentiated and anaplastic thyroid carcinoma and, in ... ...

    Abstract Poorly differentiated thyroid carcinoma (PDTC) is a rare and extremely aggressive tumor, accounting for about 2-15% of all thyroid cancer. PDTC has a distinct biological behavior compared to well-differentiated and anaplastic thyroid carcinoma and, in last years, it has been classified as a separate entity from both anatomopathological and clinical points of view. Nevertheless, there is still a lack of consensus among clinicians regarding inclusion criteria and definition of PDTC that affects its diagnosis and clinical management. Due to its rarity and difficulty in classification compared to other tumors, very few studies are available to date and series often include different histotypes in addition to PDTC. This review focuses on main studies concerning PDTC summarizing the evolution in the definition of its diagnosis criteria, clinicopathological features, management, and outcome. The data available confirm that the pathological evaluation and classification of PDTC are crucial and should therefore be standardized. Since the clinical presentation and prognosis of PDTC may vary widely depending on the different stage of the disease at diagnosis, the patient's management may differ in treatment and should be tailored to each patient. Finally, this review discusses advances in molecular insights of PDTC that, together with the implementation of both in vitro and in vivo models, will provide valuable insights into biological mechanisms of progression, metastasis, and invasion of this aggressive thyroid carcinoma. Further studies on larger, carefully selected series are needed to better assess the peculiar features of PDTC and to better define its management by focusing on the best diagnostic and therapeutic approaches.
    Language English
    Publishing date 2024-04-05
    Publishing country Italy
    Document type Journal Article
    ZDB-ID 123572-2
    ISSN 1827-1898 ; 0031-0808
    ISSN (online) 1827-1898
    ISSN 0031-0808
    DOI 10.23736/S0031-0808.23.05040-1
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Thyroid cancer and endocrine disruptive chemicals: a case-control study on per-fluoroalkyl substances and other persistent organic pollutants.

    Cirello, Valentina / Lugaresi, Marina / Moneta, Claudia / Dufour, Patrice / Manzo, Alessandro / Carbone, Erika / Colombo, Carla / Fugazzola, Laura / Charlier, Corinne / Pirard, Catherine

    European thyroid journal

    2024  Volume 13, Issue 3

    Abstract: Objective: The aim was to evaluate the possible association between some endocrine disruptive chemicals and thyroid cancer (TC) in an Italian case-control cohort.: Methods: We enrolled 112 TC patients and 112 sex- and age-matched controls without ... ...

    Abstract Objective: The aim was to evaluate the possible association between some endocrine disruptive chemicals and thyroid cancer (TC) in an Italian case-control cohort.
    Methods: We enrolled 112 TC patients and 112 sex- and age-matched controls without known thyroid diseases. Per- and poly-fluoroalkyl substances (PFAS), poly-chlorinated biphenyls (PCBs), and dichlorodiphenyltrichloroethane (4,4'-DDT and 4,4'-DDE) were measured in the serum by liquid or gas chromatography-mass spectrometry. Unconditional logistic regression, Bayesan kernel machine regression and weighted quantile sum models were used to estimate the association between TC and pollutants' levels, considered individually or as mixture. BRAFV600E mutation was assessed by standard methods.
    Results: The detection of perfluorodecanoic acid (PFDA) was positively correlated to TC (OR = 2.03, 95% CI: 1.10-3.75, P = 0.02), while a negative association was found with perfluorohexanesulfonic acid (PFHxS) levels (OR = 0.63, 95% CI: 0.41-0.98, P = 0.04). Moreover, perfluorononanoic acid (PFNA) was positively associated with the presence of thyroiditis, while PFHxS and perfluorooctane sulfonic acid (PFOS) with higher levels of presurgical thyroid-stimulating hormone (TSH). PFHxS, PFOS, PFNA, and PFDA were correlated with less aggressive TC, while poly-chlorinated biphenyls (PCB-105 and PCB-118) with larger and more aggressive tumors. Statistical models showed a negative association between pollutants' mixture and TC. BRAF V600E mutations were associated with PCB-153, PCB-138, and PCB-180.
    Conclusion: Our study suggests, for the first time in a case-control population, that exposure to some PFAS and PCBs associates with TC and some clinical and molecular features. On the contrary, an inverse correlation was found with both PFHxS and pollutants' mixture, likely due to a potential reverse causality.
    MeSH term(s) Humans ; Case-Control Studies ; Fluorocarbons/blood ; Fluorocarbons/adverse effects ; Female ; Male ; Middle Aged ; Endocrine Disruptors/blood ; Endocrine Disruptors/adverse effects ; Thyroid Neoplasms/epidemiology ; Thyroid Neoplasms/blood ; Thyroid Neoplasms/chemically induced ; Thyroid Neoplasms/genetics ; Polychlorinated Biphenyls/blood ; Polychlorinated Biphenyls/adverse effects ; Alkanesulfonic Acids/blood ; Adult ; Persistent Organic Pollutants/adverse effects ; Persistent Organic Pollutants/blood ; Aged ; Dichlorodiphenyl Dichloroethylene/blood ; Decanoic Acids/blood ; Decanoic Acids/adverse effects ; DDT/blood ; DDT/adverse effects ; Italy/epidemiology ; Caprylates/blood ; Caprylates/adverse effects ; Proto-Oncogene Proteins B-raf/genetics ; Fatty Acids/blood ; Sulfonic Acids/blood ; Mutation ; Environmental Exposure/adverse effects
    Chemical Substances perfluorodecanoic acid ; perfluorooctane sulfonic acid ; BRAF protein, human ; perfluoro-n-nonanoic acid ; hexadecafluoro-nonanoic acid
    Language English
    Publishing date 2024-05-20
    Publishing country England
    Document type Journal Article
    ZDB-ID 2659767-6
    ISSN 2235-0802 ; 2235-0640
    ISSN (online) 2235-0802
    ISSN 2235-0640
    DOI 10.1530/ETJ-23-0192
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Fetal cell microchimerism and susceptibility to COVID-19 disease in women.

    Cirello, Valentina / Lugaresi, Marina / Manzo, Alessandro / Balla, Eva / Fratianni, Gerardina / Solari, Francesca / Persani, Luca / Fugazzola, Laura / Campi, Irene

    Infection

    2023  Volume 51, Issue 4, Page(s) 1071–1078

    Abstract: Purpose: The clinical outcome of COVID-19 disease is worse in males, and the reasons of this gender disparity are currently unclear, though evidences point to a combination of biological and gender-specific factors. A phenomenon unique to the female ... ...

    Abstract Purpose: The clinical outcome of COVID-19 disease is worse in males, and the reasons of this gender disparity are currently unclear, though evidences point to a combination of biological and gender-specific factors. A phenomenon unique to the female gender is the fetal cell microchimerism (FCM), defined as the presence of fetal microchimeric cells in maternal organs and in the circulation for years after delivery and usually evaluated by assessing the presence of male cells or DNA in a woman. In the present case-control study, we aimed to evaluate the possible effect of pregnancy and related FCM on the susceptibility to SARS-CoV-2 infection and on the clinical course and outcome of COVID-19.
    Methods: One hundred twenty-three women with a previous male pregnancy, comprising 63 COVID-19 cases and 60 healthy controls were enrolled. The presence of blood male DNA was assessed by the amplification of the Y-chromosome specific gene SRY.
    Results: The prevalence of male DNA of presumed fetal origin was significantly higher in healthy controls than in COVID-19 cases (70 vs 44.4%, P = 0.0044; OR 0.3429, 95% CI 0.1631-0.7207, P = 0.0047). Among women affected with COVID-19, the presence of male FCM did not significantly influence the severity of the disease, though the 8 deceased women studied were all FCM negative.
    Conclusion: This is the first case-control study reporting the prevalence of FCM in COVID-19 and healthy women. Overall, our data seem to suggest a role for FCM in the protection towards the SARS-CoV-2 infection with a possible positive impact on clinical outcome.
    MeSH term(s) Pregnancy ; Humans ; Male ; Female ; COVID-19/epidemiology ; Chimerism ; Case-Control Studies ; SARS-CoV-2 ; DNA
    Chemical Substances DNA (9007-49-2)
    Language English
    Publishing date 2023-03-01
    Publishing country Germany
    Document type Case Reports ; Journal Article
    ZDB-ID 185104-4
    ISSN 1439-0973 ; 0300-8126 ; 0173-2129
    ISSN (online) 1439-0973
    ISSN 0300-8126 ; 0173-2129
    DOI 10.1007/s15010-023-02006-x
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Correction: Fetal cell microchimerism and susceptibility to COVID-19 disease in women.

    Cirello, Valentina / Lugaresi, Marina / Manzo, Alessandro / Balla, Eva / Fratianni, Gerardina / Solari, Francesca / Persani, Luca / Fugazzola, Laura / Campi, Irene

    Infection

    2023  Volume 51, Issue 4, Page(s) 1079

    Language English
    Publishing date 2023-05-11
    Publishing country Germany
    Document type Published Erratum
    ZDB-ID 185104-4
    ISSN 1439-0973 ; 0300-8126 ; 0173-2129
    ISSN (online) 1439-0973
    ISSN 0300-8126 ; 0173-2129
    DOI 10.1007/s15010-023-02037-4
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Absence of the MAP2K5 germline variants c.G961A and c.T1100C in a wide series of familial nonmedullary thyroid carcinoma Italian families.

    Cirello, Valentina / Colombo, Carla / Persani, Luca / Fugazzola, Laura

    International journal of cancer

    2019  Volume 145, Issue 2, Page(s) 600

    MeSH term(s) Carcinoma, Papillary/genetics ; Exome ; Germ Cells ; Humans ; MAP Kinase Kinase 5 ; Thyroid Cancer, Papillary ; Thyroid Neoplasms/genetics
    Chemical Substances MAP Kinase Kinase 5 (EC 2.7.12.2) ; MAP2K5 protein, human (EC 2.7.12.2)
    Language English
    Publishing date 2019-03-19
    Publishing country United States
    Document type Letter ; Research Support, Non-U.S. Gov't ; Comment
    ZDB-ID 218257-9
    ISSN 1097-0215 ; 0020-7136
    ISSN (online) 1097-0215
    ISSN 0020-7136
    DOI 10.1002/ijc.32244
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Novel insights into the link between fetal cell microchimerism and maternal cancers.

    Cirello, Valentina / Fugazzola, Laura

    Journal of cancer research and clinical oncology

    2016  Volume 142, Issue 8, Page(s) 1697–1704

    Abstract: Introduction: Fetal cell microchimerism (FCM) is defined as the persistence of fetal cells in the mother for decades after pregnancy without any apparent rejection. Fetal microchimeric cells (fmcs) engraft the maternal bone marrow and are able to ... ...

    Abstract Introduction: Fetal cell microchimerism (FCM) is defined as the persistence of fetal cells in the mother for decades after pregnancy without any apparent rejection. Fetal microchimeric cells (fmcs) engraft the maternal bone marrow and are able to migrate through the circulation and to reach tissues. In malignancies, the possible role of fmcs is still controversial, several studies advising a protective and repairing function, and other postulating a beneficial role in the progression of the disease. At the peripheral blood level, FCM is less frequently observed in women with several solid and hematological neoplasia with respect to healthy controls, suggesting a beneficial role in cancer surveillance. At the tissue level, fmcs were documented in neoplastic lesions of thyroid, breast, cervix, lung and melanoma, displaying epithelial, hematopoietic, mesenchymal and endothelial lineage differentiation. Fmcs expressing hematopoietic markers were hypothesized to have a role in the attack to neoplastic cells, whereas those expressing epithelial or mesenchymal antigens could be involved in repair and replacement of damaged cells. On the other hand, fetal cells showing an endothelial phenotype could have a role in tumor evolution and progression. The positive effect of FCM is supported by findings in animal models.
    Conclusions: This review provides an extensive overview of the link between fetal cell microchimerism and maternal cancers. Moreover, biological mechanisms by which fetal cell microchimerism is believed to modulate the protection against cancer development or tumor progression will be discussed, together with findings in animal models.
    MeSH term(s) Chimerism ; Female ; Fetus/cytology ; Humans ; Maternal-Fetal Exchange ; Neoplasms/pathology ; Pregnancy
    Language English
    Publishing date 2016-08
    Publishing country Germany
    Document type Journal Article ; Review
    ZDB-ID 134792-5
    ISSN 1432-1335 ; 0171-5216 ; 0084-5353 ; 0943-9382
    ISSN (online) 1432-1335
    ISSN 0171-5216 ; 0084-5353 ; 0943-9382
    DOI 10.1007/s00432-015-2110-3
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: Clinical and Genetic Features of a Large Monocentric Series of Familial Non-Medullary Thyroid Cancers.

    Cirello, Valentina / Colombo, Carla / Karapanou, Olga / Pogliaghi, Gabriele / Persani, Luca / Fugazzola, Laura

    Frontiers in endocrinology

    2021  Volume 11, Page(s) 589340

    Abstract: Several low penetration susceptibility risk loci or genes have been proposed in recent years with a possible causative role for familial non-medullary thyroid cancer (FNMTC), though the results are still not conclusive or reliable. Among all the ... ...

    Abstract Several low penetration susceptibility risk loci or genes have been proposed in recent years with a possible causative role for familial non-medullary thyroid cancer (FNMTC), though the results are still not conclusive or reliable. Among all the candidates, here fully reviewed, a new extremely rare germline variant c.3607A>G (p.Y1203H) of the
    MeSH term(s) Adolescent ; Adult ; Aged ; Aged, 80 and over ; Biomarkers, Tumor/genetics ; Child ; Dual Oxidases/genetics ; Female ; Follow-Up Studies ; Genetic Predisposition to Disease ; Germ-Line Mutation ; Humans ; Male ; Middle Aged ; Prognosis ; Thyroid Cancer, Papillary/genetics ; Thyroid Cancer, Papillary/pathology ; Thyroid Cancer, Papillary/surgery ; Thyroid Neoplasms/genetics ; Thyroid Neoplasms/pathology ; Thyroid Neoplasms/surgery ; Young Adult
    Chemical Substances Biomarkers, Tumor ; Dual Oxidases (EC 1.11.1.-) ; DUOX2 protein, human (EC 1.6.3.1)
    Language English
    Publishing date 2021-01-07
    Publishing country Switzerland
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2592084-4
    ISSN 1664-2392
    ISSN 1664-2392
    DOI 10.3389/fendo.2020.589340
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Thyroid cancer harboring

    Colombo, Carla / Pogliaghi, Gabriele / Tosi, Delfina / Muzza, Marina / Bulfamante, Gaetano / Persani, Luca / Fugazzola, Laura / Cirello, Valentina

    Frontiers in oncology

    2022  Volume 12, Page(s) 949098

    Abstract: To date, the molecular mechanisms that underline aggressiveness and resistance to tyrosine kinase inhibitors in some thyroid carcinomas (TCs) are not known yet. We report the case of a young patient with a metastatic poorly differentiated (PDTC) and ... ...

    Abstract To date, the molecular mechanisms that underline aggressiveness and resistance to tyrosine kinase inhibitors in some thyroid carcinomas (TCs) are not known yet. We report the case of a young patient with a metastatic poorly differentiated (PDTC) and follicular thyroid carcinoma (FTC) refractory to conventional therapies and to Sorafenib. The patient, despite an initial partial response, died of progressive disease 21 months after diagnosis. The genetic analysis performed on the primary tumor and on lymph nodes and distant metastases allowed to identify a frameshift mutation (p.P248Tfs*5) in the
    Language English
    Publishing date 2022-09-02
    Publishing country Switzerland
    Document type Case Reports
    ZDB-ID 2649216-7
    ISSN 2234-943X
    ISSN 2234-943X
    DOI 10.3389/fonc.2022.949098
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Positive effect of fetal cell microchimerism on tumor presentation and outcome in papillary thyroid cancer.

    Cirello, Valentina / Fugazzola, Laura

    Chimerism

    2015  Volume 5, Issue 3-4, Page(s) 106–108

    Abstract: Studies on both circulating and tissue fetal cell microchimerism (FCM) favored its protective role in thyroid cancer, consistent with findings in other malignancies. Nevertheless, scanty data were available on the possible impact on the outcome of the ... ...

    Abstract Studies on both circulating and tissue fetal cell microchimerism (FCM) favored its protective role in thyroid cancer, consistent with findings in other malignancies. Nevertheless, scanty data were available on the possible impact on the outcome of the disease. We demonstrated that FCM has a positive effect on thyroid cancer presentation and outcome. We also excluded that the better clinical features observed were due to the effect of pregnancy per se. In conclusion, FCM may have not only a protective role toward the onset of thyroid cancer, but also a positive effect on its progression. These findings give novel insights into the identification of the role of FCM in oncology and, consequently, in the potential therapeutic application of this physiological phenomenon.
    MeSH term(s) Carcinoma/epidemiology ; Carcinoma/genetics ; Carcinoma/pathology ; Carcinoma, Papillary ; Chimerism ; Female ; Humans ; Pregnancy ; Pregnancy Complications, Neoplastic/epidemiology ; Pregnancy Complications, Neoplastic/genetics ; Pregnancy Complications, Neoplastic/pathology ; Protective Factors ; Thyroid Cancer, Papillary ; Thyroid Gland/metabolism ; Thyroid Gland/pathology ; Thyroid Neoplasms/epidemiology ; Thyroid Neoplasms/genetics ; Thyroid Neoplasms/pathology
    Language English
    Publishing date 2015-12-08
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2660084-5
    ISSN 1938-1964 ; 1938-1956
    ISSN (online) 1938-1964
    ISSN 1938-1956
    DOI 10.1080/19381956.2015.1107254
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top